(Q24201662)

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Corticosteroid use in the treatment of neuromuscular disorders: empirical and evidence-based data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Remarkable recovery of a steroid-responsive recurrent polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Progressive muscle weakness after high-dose steroids in two children with CIDP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Recurrent and chronic relapsing Guillain-Barré polyneuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Pe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Electrophysiological predictors of steroid-responsiveness in chronic inflammatory demyelinating polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Chronic relapsing polyneuritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Pe

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021

Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002062.PUB2

7 January 2021